Innovent Biologics Inc
HKEX:1801
Innovent Biologics Inc
Cash from Investing Activities
Innovent Biologics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Innovent Biologics Inc
HKEX:1801
|
Cash from Investing Activities
-¥1.1B
|
CAGR 3-Years
41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash from Investing Activities
¥2.4B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Investing Activities
-¥2.1B
|
CAGR 3-Years
-91%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
|
Cash from Investing Activities
-¥36.1m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
19%
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Investing Activities
-¥993.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-14%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Investing Activities
-¥943.7m
|
CAGR 3-Years
-233%
|
CAGR 5-Years
-143%
|
CAGR 10-Years
N/A
|
See Also
What is Innovent Biologics Inc's Cash from Investing Activities?
Cash from Investing Activities
-1.1B
CNY
Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Cash from Investing Activities amounts to -1.1B CNY.
What is Innovent Biologics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
41%
Over the last year, the Cash from Investing Activities growth was 24%. The average annual Cash from Investing Activities growth rates for Innovent Biologics Inc have been 41% over the past three years .